Murphy Spadaro & Landon

Delaware

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases35

Challenger50%

Patent Owner50%

NPE50%

Practice Areas

BiotechChemicalMech Eng, Manuf

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
08/30/24	Vertex Pharmaceuticals Inc v. Lupin Ltd 1:22-CV-00966 ( D. DE )	NOTICE OF SERVICE of Plaintiff's Opening Claim Construction Brief filed by Vertex Pharmaceuticals Incorporated.(Fahnestock, Derek) (Entered: 08/30/2024)
01/03/24	Vertex Pharmaceuticals Inc v. Sun Pharmaceutical Industries Ltd 1:20-CV-00988 ( D. DE )	Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,646,481 B2. (Attachments: # 1 Order)(nms) (Entered: 01/03/2024)
02/03/23	Genentech Inc v. Sandoz Inc 1:19-CV-00078 ( D. DE )	Joint Letter to The Clerk of Court, regarding the discarding of trial exhibits (D.I. 438 ). (Clark, Cameron) Modified on 2/3/2023 (nms). (Entered: 02/03/2023)
02/03/23	Genentech Inc v. Sandoz Inc 1:19-CV-00078 ( D. DE )	Remark: The bench trial exhibits (see D.I. 362 Exhibit List) have been destroyed per the authority at D.I. 439 . (nms) (Entered: 02/03/2023)
	Genentech Inc v. Lupin Ltd 1:19-CV-00109 ( D. DE )	CASE CLOSED per entry of D.I. 326 in Lead Civil Action 19-78-RGA. (nms)
	Genentech Inc v. Lupin Ltd 1:19-CV-00110 ( D. DE )	CASE CLOSED per entry of D.I. 326 in Lead Civil Action 19-78-RGA. (nms)
10/15/21	Genentech Inc v. Lupin Ltd 1:19-CV-00110 ( D. DE )	Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 7,767,225 B2; 7,988,994 B2; 8,383,150 B2; 8,753,679 B2; 7,696,236 B2; 7,767,700 B2; 8,420,674 B2; 7,566,729 B1; 7,635,707 B1; 8,592,462 B2; 8,609,701 B2; 7,816,383 B1; 7,910,610 B1; 8,013,002 B2; 8,084,475 B2; 8,318,780 B2; 8,648,098 B2; 8,754,109 B2; 8,778,947 B2. (Attachments: # 1 Order)(nms) (Entered: 10/15/2021) Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 7,767,225 B2; 7,988,994 B2; 8,383,150 B2; 8,753,679 B2; 7,696,236 B2; 7,767,700 B2; 8,420,674 B2; 7,566,729 B1; 7,635,707 B1; 8,592,462 B2; 8,609,701 B2; 7,816,383 B1; 7,910,610 B1; 8,013,002 B2; 8,084,475 B2; 8,318,780 B2; 8,648,098 B2; 8,754,109 B2; 8,778,947 B2. (Attachments: # 1 Order)(nms) (Entered: 10/15/2021)
10/15/21	Genentech Inc v. Lupin Ltd 1:19-CV-00109 ( D. DE )	Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 7,767,225 B2; 7,988,994 B2; 8,383,150 B2; 8,753,679 B2; 7,696,236 B2; 7,767,700 B2; 8,420,674 B2; 7,566,729 B1; 7,635,707 B1; 8,592,462 B2; 8,609,701 B2; 7,816,383 B1; 7,910,610 B1; 8,013,002 B2; 8,084,475 B2; 8,318,780 B2; 8,648,098 B2; 8,754,109 B2; 8,778,947 B2. (Attachments: # 1 Order)(nms) (Entered: 10/15/2021) Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 7,767,225 B2; 7,988,994 B2; 8,383,150 B2; 8,753,679 B2; 7,696,236 B2; 7,767,700 B2; 8,420,674 B2; 7,566,729 B1; 7,635,707 B1; 8,592,462 B2; 8,609,701 B2; 7,816,383 B1; 7,910,610 B1; 8,013,002 B2; 8,084,475 B2; 8,318,780 B2; 8,648,098 B2; 8,754,109 B2; 8,778,947 B2. (Attachments: # 1 Order)(nms) (Entered: 10/15/2021)
10/15/21	Genentech Inc v. Lupin Ltd 1:19-CV-00109 ( D. DE )	CASE CLOSED per entry of D.I. 326 in Lead Civil Action 19-78-RGA. (nms) (Entered: 10/15/2021)
10/15/21	Genentech Inc v. Lupin Ltd 1:19-CV-00109 ( D. DE )	Final Civil Docket 10-15-2021